January 24, 2023An eye-opening solution for tissue samples – launch of NaveniFlex™ Tissue Read more about An eye-opening solution for tissue samples – launch of NaveniFlex™ Tissue →
November 30, 2022Discover the secret life of proteins – concurrently visualize two proteins in a free and complex stateRead more about Discover the secret life of proteins – concurrently visualize two proteins in a free and complex state →
September 14, 2022Here to make a difference – the first PD1/PD-L1 interaction assayRead more about Here to make a difference – the first PD1/PD-L1 interaction assay →
August 22, 2022Low signal and multiple non-specific bands in your Western Blot? Learn how to surpass the problemsRead more about Low signal and multiple non-specific bands in your Western Blot? Learn how to surpass the problems →
July 12, 2022Navinci Diagnostics AB announces closing of SEK 90M Series A financing, led by Segulah Medical Acceleration with support from existing shareholdersRead more about Navinci Diagnostics AB announces closing of SEK 90M Series A financing, led by Segulah Medical Acceleration with support from existing shareholders →
June 21, 2022Coming soon! Naveni PD1/PD-L1 and Naveni pY PD1Read more about Coming soon! Naveni PD1/PD-L1 and Naveni pY PD1 →
May 17, 2022Launch News – pY VEGFR2. Navinci is expanding the Naveni PTM product line.Read more about Launch News – pY VEGFR2. Navinci is expanding the Naveni PTM product line. →
April 12, 2022Launch News – NaveniBright kits. Proximity Ligation Assay now with bright-field read out.Read more about Launch News – NaveniBright kits. Proximity Ligation Assay now with bright-field read out. →
March 23, 2022Navinci Diagnostics partners with Ozyme for the distribution of Naveni products in France.Read more about Navinci Diagnostics partners with Ozyme for the distribution of Naveni products in France. →
October 5, 2021Navinci and SciLife enters collaboration: Naveni in situ Proximity Ligation Assay technique will be provided by the SciLifeLab unit Affinity Proteomics Uppsala.Read more about Navinci and SciLife enters collaboration: Naveni in situ Proximity Ligation Assay technique will be provided by the SciLifeLab unit Affinity Proteomics Uppsala. →
September 24, 2021Navinci partners with Oncolab GmbH, Austria, to supply reagents to their P53 Prions – A novel biomarker test for circulating tumor cellsRead more about Navinci partners with Oncolab GmbH, Austria, to supply reagents to their P53 Prions – A novel biomarker test for circulating tumor cells →
